<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/628">
    <title>DSpace Community: Principal Investigator- Dr. Vijay Kumar Yadav</title>
    <link>https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/628</link>
    <description>Principal Investigator- Dr. Vijay Kumar Yadav</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1423" />
        <rdf:li rdf:resource="https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1422" />
        <rdf:li rdf:resource="https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1027" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-27T15:40:39Z</dc:date>
  </channel>
  <item rdf:about="https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1423">
    <title>Mediation of the Acute Stress Response by the Skeleton</title>
    <link>https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1423</link>
    <description>Title: Mediation of the Acute Stress Response by the Skeleton
Authors: Yadav, Vijay Kumar; Rahmouni, Kamal; Gao, Xiao-Bing; Karsenty, Gerard; Berger, Julian Meyer; Singh, Parminder; Khrimian, Lori; Morgan, Donald A; Chowdhury, Subrata; Arteaga-Solis, Emilio; Horvath, Tamas L; Domingos, Ana I; Marsland, Anna L
Abstract: We hypothesized that bone evolved, in part, to enhance the ability of bony vertebrates to escape danger in the wild. In support of this notion, we show here that a bone-derived signal is necessary to develop an acute stress response (ASR). Indeed, exposure to various types of stressors in mice, rats (rodents), and humans leads to a rapid and selective surge of circulating bioactive osteocalcin because stressors favor the uptake by osteoblasts of glutamate, which prevents inactivation of osteocalcin prior to its secretion. Osteocalcin permits manifestations of the ASR to unfold by signaling in post-synaptic parasympathetic neurons to inhibit their activity, thereby leaving the sympathetic tone unopposed. Like wild-type animals, adrenalectomized rodents and adrenal-insufficient patients can develop an ASR, and genetic studies suggest that this is due to their high circulating osteocalcin levels. We propose that osteocalcin defines a bony-vertebrate-specific endocrine mediation of the ASR.</description>
    <dc:date>2019-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1422">
    <title>Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway</title>
    <link>https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1422</link>
    <description>Title: Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway
Authors: Yadav, Vijay Kumar; Sharan, Kunal; Lewis, Kirsty; Furukawa, Takahisa
Abstract: Tryptophan, an essential amino acid through a series of enzymatic reactions gives rise to various metabolites, viz. serotonin and melatonin, that regulate distinct biological functions. We show here that tryptophan metabolism in the pineal gland favors bone mass accrual through production of melatonin, a pineal-derived neurohormone. Pineal gland-specific deletion of Tph1, the enzyme that catalyzes the first step in the melatonin biosynthesis lead to a decrease in melatonin levels and a low bone mass due to an isolated decrease in bone formation while bone resorption parameters remained unaffected. Skeletal analysis of the mice deficient in MT1 or MT2 melatonin receptors showed a low bone mass in MT2-/- mice while MT1-/- mice had a normal bone mass compared to the WT mice. This low bone mass in the MT2-/- mice was due to an isolated decrease in osteoblast numbers and bone formation. In vitro assays of the osteoblast cultures derived from the MT1-/- and MT2-/- mice showed a cell intrinsic defect in the proliferation, differentiation and mineralization abilities of MT2-/- osteoblasts compared to WT counterparts, and the mutant cells did not respond to melatonin addition. Finally, we demonstrate that daily oral administration of melatonin can increase bone accrual during growth and can cure ovariectomy-induced structural and functional degeneration of bone by specifically increasing bone formation. By identifying pineal-derived melatonin as a regulator of bone mass through MT2 receptors, this study expands the role played by tryptophan derivatives in the regulation of bone mass and underscores its therapeutic relevance in postmenopausal osteoporosis.</description>
    <dc:date>2017-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1027">
    <title>Skeletal Site-specific Changes in Bone Mass in a Genetic Mouse Model for Human 15q11-13 Duplication Seen in Autism</title>
    <link>https://dspace.nii.res.in//https://dspace.nii.res.in/handle/123456789/1027</link>
    <description>Title: Skeletal Site-specific Changes in Bone Mass in a Genetic Mouse Model for Human 15q11-13 Duplication Seen in Autism
Authors: Yadav, Vijay Kumar; Lewis, Kirsty E; Sharan, Kunal; Takumi, Toru
Abstract: Children suffering from autism have been reported to have low bone mineral density and increased risk for fracture, yet the cellular origin of the bone phenotype remains unknown. Here we have utilized a mouse model of autism that duplicates 6.3 Mb region of chromosome 7 (Dp/+) corresponding to a region of chromosome 15q11-13, duplication of which is recurrent in humans to characterize the bone phenotype. Paternally inherited Dp/+ (patDp/+) mice showed expected increases in the gene expression in bone, normal postnatal growth and body weight acquisition compared to the littermate controls. Four weeks-old patDp/+ mice develop a low bone mass phenotype in the appendicular but not the axial skeleton compared to the littermate controls. This low bone mass in the mutant mice was secondary to a decrease in the number of osteoblasts and bone formation rate while the osteoclasts remained relatively unaffected. Further in vitro cell culture experiments and gene expression analysis revealed a major defect in the proliferation, differentiation and mineralization abilities of patDp/+ osteoblasts while osteoclast differentiation remained unchanged compared to controls. This study therefore characterizes the structural and cellular bone phenotype in a mouse model of autism that can be further utilized to investigate therapeutic avenues to treat bone fractures in children with autism.</description>
    <dc:date>2017-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

